GlassScriptPhysician profile
Steven S Tsoraides
NPI 1760689764
$2,215.32
in general payments reported to CMS, 2019-2025
19 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $384 · 2020: $191 · 2021: $557 · 2022: $613 · 2023: $225 · 2024: $111 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $471.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $700.58 | 2019-2023 | Da Vinci Surgical System |
| Boston Scientific Corporation | $331.11 | 2020-2023 | Spyglass Discover |
| Takeda Pharmaceuticals U.S.A., INC. | $257.35 | 2021-2025 | Gattex, Entyvio, Eohilia |
| Ethicon US, LLC | $204.11 | 2020-2025 | Enseal X1, Echelon Flex, Megadyne |
| Braintree Laboratories, INC. | $166.67 | 2019 | |
| W. L. Gore & Associates, INC. | $123.72 | 2022 | |
| Kls-Martin L.P. | $85.08 | 2021 | |
| Myriad Genetic Laboratories, INC. | $65.05 | 2021-2023 | Myrisk |
| Merck Sharp & Dohme LLC | $64.90 | 2019-2025 | Bridion |
| Abbvie INC. | $62.08 | 2024-2025 | |
| Csl Behring | $27.28 | 2021 | |
| Medtronic, INC. | $22.02 | 2022 | |
| Axonics, INC. | $20.30 | 2024 | Axonics |
| Polynovo North America LLC | $15.89 | 2023 | |
| Allergan, INC. | $15.85 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baudax Bio INC. | $15.69 | 2020 | |
| Janssen Biotech, INC. | $15.53 | 2025 | Simponi Aria, Stelara, Simponi |
| Bolder Surgical LLC | $11.35 | 2021 | |
| Biomerieux INC | $10.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Tsoraides listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.